Description
Metagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus who are not adequately controlled on metformin or sitagliptin alone or in patients already being treated with the combination of sitagliptin and metformin.
Important Limitations of Use: Metagliptin should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis.
